Centogene Past Earnings Performance

Past criteria checks 0/6

Centogene's earnings have been declining at an average annual rate of -18%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 0.8% per year.

Key information

-18.0%

Earnings growth rate

-9.8%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate0.8%
Return on equityn/a
Net Margin-73.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Take Care Before Jumping Onto Centogene N.V. (NASDAQ:CNTG) Even Though It's 36% Cheaper

Aug 06
Take Care Before Jumping Onto Centogene N.V. (NASDAQ:CNTG) Even Though It's 36% Cheaper

Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

Feb 16
Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

Centogene N.V. (NASDAQ:CNTG) Might Not Be As Mispriced As It Looks

Dec 21
Centogene N.V. (NASDAQ:CNTG) Might Not Be As Mispriced As It Looks

Centogene GAAP EPS of -€0.28, revenue of €10.32M

Jul 15

Is Centogene (NASDAQ:CNTG) Using Debt In A Risky Way?

Nov 25
Is Centogene (NASDAQ:CNTG) Using Debt In A Risky Way?

Is Centogene (NASDAQ:CNTG) Using Debt Sensibly?

Jun 29
Is Centogene (NASDAQ:CNTG) Using Debt Sensibly?

Centogene reports Q1 results

Jun 16

Centogene, Alector initiate EFRONT study in frontotemporal dementia

Jun 02

Centogene to nominate Rene Just as CFO at the upcoming Annual General Meeting

May 26

Need To Know: Analysts Are Much More Bullish On Centogene N.V. (NASDAQ:CNTG)

Apr 17
Need To Know: Analysts Are Much More Bullish On Centogene N.V. (NASDAQ:CNTG)

What Percentage Of Centogene N.V. (NASDAQ:CNTG) Shares Do Insiders Own?

Mar 05
What Percentage Of Centogene N.V. (NASDAQ:CNTG) Shares Do Insiders Own?

Revenue & Expenses Breakdown

How Centogene makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CNTG.F Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2349-364612
30 Sep 2350-384514
30 Jun 2351-404515
31 Mar 2349-404416
31 Dec 2247-394217
30 Sep 22-15-444620
30 Jun 222-584920
31 Mar 22190-445520
31 Dec 2142-575419
30 Sep 21162-405917
30 Jun 21168-245718
31 Mar 21126-275517
01 Jan 2138-604915
30 Sep 2073-304314
30 Jun 2049-283911
31 Mar 2050-243511
31 Dec 1949-213310
30 Sep 1944-19309
30 Jun 1945-16308
31 Mar 1943-13287
31 Dec 1840-11266
30 Sep 1839-9237
31 Dec 1732-5156
31 Dec 1628-5146

Quality Earnings: CNTG.F is currently unprofitable.

Growing Profit Margin: CNTG.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CNTG.F is unprofitable, and losses have increased over the past 5 years at a rate of 18% per year.

Accelerating Growth: Unable to compare CNTG.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CNTG.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).


Return on Equity

High ROE: CNTG.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 03:07
End of Day Share Price 2024/12/24 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Centogene N.V. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Sung Ji NamBTIG
Erin Wilson WrightCredit Suisse